|1.||Tursi, James P: 8 articles (11/2015 - 01/2013)|
|2.||Kaufman, Gregory J: 7 articles (11/2015 - 01/2013)|
|3.||Smith, Ted: 7 articles (08/2015 - 06/2012)|
|4.||Hellstrom, Wayne J G: 5 articles (12/2015 - 07/2013)|
|5.||Coleman, Stephen: 5 articles (10/2015 - 12/2010)|
|6.||Kaplan, F Thomas D: 5 articles (09/2015 - 09/2009)|
|7.||Hurst, Lawrence C: 4 articles (10/2015 - 09/2009)|
|8.||Matsushita, Osamu: 4 articles (01/2015 - 09/2008)|
|9.||Levine, Laurence A: 4 articles (01/2015 - 06/2012)|
|10.||Gerber, Robert A: 4 articles (04/2014 - 11/2011)|
|1.||Dupuytren Contracture (Dupuytrens Contracture)
12/01/2010 - "Collagenase clostridium histolyticum is the first Food and Drug Administration-approved, nonsurgical treatment option for adult Dupuytren's contracture patients with a palpable cord that is highly effective and well tolerated. "
08/01/2015 - "Collagenase clostridium histolyticum injection proved to be an effective and safe treatment for Dupuytren contracture. "
09/01/2011 - "Collagenase clostridium histolyticum is a novel treatment for Dupuytren's contracture, approved by the U.S. "
12/01/2013 - "This study was designed to provide comparative information on the safety and efficacy of injection with collagenase clostridium histolyticum (CCH) and fasciectomy for patients with Dupuytren's contracture (DC). "
07/01/2015 - "Collagenase Clostridium Histolyticum versus Limited Fasciectomy for Dupuytren's Contracture: Outcomes from a Multicenter Propensity Score Matched Study."
|2.||Penile Induration (Peyronie's Disease)
11/01/2015 - "Re: Clinical Efficacy of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease by Subgroup: Results from two Large, Double-Blind, Randomized, Placebo-Controlled, Phase III Studies."
11/01/2015 - "Re: Clinical Efficacy of Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease by Subgroups: Results from Two Large, Double-blind, Randomized, Placebo-controlled, Phase III Studies."
10/01/2015 - "Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies."
10/01/2015 - "To examine the efficacy of intralesional collagenase Clostridium histolyticum (CCH) in defined subgroups of patients with Peyronie's disease (PD). "
01/01/2015 - "Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study."
07/01/2015 - "This propensity score-matched study showed that collagenase clostridium histolyticum was not significantly different from limited fasciectomy in reducing metacarpophalangeal joint contractures, whereas proximal interphalangeal joint contractures showed slightly better reduction following limited fasciectomy. "
07/01/2015 - "This study evaluated all subjects treated with collagenase clostridium histolyticum or limited fasciectomy for metacarpophalangeal and/or proximal interphalangeal joint contractures between 2011 and 2014 at seven practice sites. "
10/01/2011 - "2 clinical phase III studies showed that contractures could be effectively reduced when using Collagenase clostridium histolyticum. "
10/01/2015 - "Outcome of Dupuytren's Contractures After Collagenase Clostridium Histolyticum Injection: A Single Institution Experience."
05/01/2015 - "Collagenase clostridium histolyticum was effective and well tolerated in the short term in patients with Dupuytren PIP joint contractures. "
|4.||Congenital Abnormalities (Deformity)
01/01/2015 - "Collagenase clostridium histolyticum (CCH) is an Food and Drug Administration-approved intralesional injection for treatment of Peyronie's disease (PD) that has been shown to reduce penile curvature deformity and PD symptom bother in phase 2b and phase 3 placebo-controlled clinical trials. "
07/01/2014 - "Treatments that have decreased penile curvature deformity in Level 1 or Level 2 evidence-based, placebo-controlled studies include intralesional injection with interferon α-2b or collagenase clostridium histolyticum. "
|5.||Leiomyoma (Uterine Fibroids)
12/01/2014 - "Purified Clostridium histolyticum collagenase (CHC), an Food and Drug Administration-approved drug that does not affect nerves or blood vessels, was assessed as a potential treatment for fibroids in this proof-of-principle study. "
12/01/2014 - "Injectable Clostridium histolyticum collagenase as a potential treatment for uterine fibroids."
|4.||propylene diquat (PDQ(+))
|5.||prolyl oligopeptidase (prolyl endopeptidase)
|7.||Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)
|8.||Peptide Hydrolases (Proteases)
|10.||Immunoglobulin G (IgG)